A Study to Evaluate the Effectiveness and Safety of MEDI-528 in Adults
Public ClinicalTrials.gov record NCT00968669. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous MEDI-528 in Adults With Uncontrolled Asthma
Study identification
- NCT ID
- NCT00968669
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- MedImmune LLC
- Industry
- Enrollment
- 329 participants
Conditions and interventions
Conditions
Interventions
- MEDI528 100 mg Biological
- MEDI528 30 mg Biological
- MEDI528 300 mg Biological
- Placebo Other
Biological · Other
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2009
- Primary completion
- Oct 31, 2011
- Completion
- Dec 31, 2011
- Last update posted
- Jun 3, 2014
2009 – 2012
United States locations
- U.S. sites
- 24
- U.S. states
- 18
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Pell City | Alabama | 35128 | — |
| Research Site | Los Angeles | California | 90025 | — |
| Research Site | Sacramento | California | 95819 | — |
| Research Site | San Diego | California | 92123 | — |
| Research Site | Centennial | Colorado | 80112 | — |
| Research Site | Colarado Springs | Colorado | 80907 | — |
| Research Site | Thornton | Colorado | 80233 | — |
| Research Site | Waterbury | Connecticut | 06708 | — |
| Research Site | Kissimmee | Florida | 34741 | — |
| Research Site | Normal | Illinois | 61761 | — |
| Research Site | Overland Park | Kansas | 66210 | — |
| Research Site | Louisville | Kentucky | 40215 | — |
| Research Site | Baltimore | Maryland | 21236 | — |
| Research Site | Silver Spring | Maryland | 20902 | — |
| Research Site | North Dartmouth | Massachusetts | 02747 | — |
| Research Site | Minneapolis | Minnesota | 55402 | — |
| Research Site | Omaha | Nebraska | 68131 | — |
| Research Site | Mount Laurel | New Jersey | 08054 | — |
| Research Site | Sylvania | Ohio | 43560 | — |
| Research Site | Medford | Oregon | 97504 | — |
| Research Site | Lincoln | Rhode Island | 02865 | — |
| Research Site | Greenville | South Carolina | 29607 | — |
| Research Site | El Paso | Texas | 79903 | — |
| Research Site | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00968669, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 3, 2014 · Synced May 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00968669 live on ClinicalTrials.gov.